Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0032285 (
pneumonia
)
54,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SHIP-1
has an important role in controlling immune cell function through its ability to downmodulate PI3K signaling pathways that regulate cell survival and responses to stimulation. Mice deficient in
SHIP-1
display several chronic inflammatory phenotypes including antibody-mediated autoimmune disease, Crohn's disease-like ileitis and a lung disease reminiscent of chronic obstructive pulmonary disease. The ileum and lungs of
SHIP-1
-deficient mice are infiltrated at an early age with abundant myeloid cells and the mice have a limited lifespan primarily thought to be due to the consolidation of lungs with spontaneously activated macrophages. To determine whether the myeloid compartment is the key initiator of inflammatory disease in
SHIP-1
-deficient mice, we examined two independent strains of mice harboring myeloid-restricted deletion of
SHIP-1
. Contrary to expectations, conditional deletion of
SHIP-1
in myeloid cells did not result in consolidating
pneumonia
or segmental ileitis typical of germline
SHIP-1
deficiency. In addition, other myeloid cell abnormalities characteristic of germline loss of
SHIP-1
, including flagrant splenomegaly and enhanced myelopoiesis, were absent in mice lacking
SHIP-1
in myeloid cells. This study indicates that the spontaneous inflammatory disease characteristic of germline
SHIP-1
deficiency is not initiated solely by LysM-positive myeloid cells but requires the simultaneous loss of
SHIP-1
in other hematolymphoid lineages.
...
PMID:SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammation. 2459 98
T cells have a critical role in immune surveillance at mucosal surfaces.
SHIP1
(-/-) mice succumb to mucosal inflammatory disease that afflicts the lung and small intestine (SI). The basis of this condition has not been defined. Here we show that
SHIP1
is required for the normal persistence and survival of T cells in mucosal tissues. We find that CD4 and CD8 effector T cells are reduced; however, Treg cells are increased in the SI and lungs of
SHIP1
(-/-) and CD4CreSHIP(flox/flox) mice. Furthermore, a subset of T cells in the SI of
SHIP1
(-/-) mice are FasL(+) and are more susceptible to extrinsic cell death. Mechanistic analyses showed that
SHIP1
associates with the death receptor CD95/Fas and treatment with a Caspase 8 inhibitor prevents
SHIP1
inhibitor-mediated T-cell death. Notably, mucosal inflammation in
SHIP1
(-/-) mice is reduced by treatment with a Caspase 8 inhibitor. We also find that the incidence of Crohn's disease (CD) and
pneumonia
is significantly increased in mice with dual T and myeloid lineage
SHIP1
deletion but not in single lineage-deleted mice. Thus, by promoting survival of protective T cells, thereby preventing an inflammatory myeloid response,
SHIP1
maintains an appropriate balance of innate immune function at mucosal surfaces necessary for immune homeostasis.
...
PMID:Impaired T-cell survival promotes mucosal inflammatory disease in SHIP1-deficient mice. 2478 Oct 51